熊艺
机构：Central South University, Hunan Cancer Hospital
发表论文 4 篇 · 总被引 1 次 · h-index 1
代表论文
- Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial (2026 · Nature Medicine · 被引 1)
- Efficacy and biomarker exploration of anlotinib plus penpulimab in second-line ES-SCLC: Results from the phase 2 ALTER-L041 trial (2026 · Cell Reports Medicine)
- High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial (2026 · Cell Reports Medicine)
- 高通量测序解析肿瘤患者 MET 突变谱及靶向用药免疫组化筛查的价值 (2026 · DOAJ (DOAJ: Directory of Open Access Journals))